5 Best Stocks Under $10 According to Billionaire Daniel Och’s OZ Management

3. Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

OZ Management’s Stake Value: $6,616,000
Percent of OZ Management’s 13F Portfolio: 0.04%
Number of Hedge Fund Holders: 8
Share Price as of October 5: $6.36

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is an American biotech company that is focused on the development and commercialization of synthetic DNA products. The company’s discoveries mainly treat patients suffering from rare and serious diseases, such as cancer. It ranks third on our list of the best stocks under $10 according to billionaire Daniel Och’s OZ Management.

In Q2 2021, OZ Management increased its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) by 133% and now holds 713,700 shares in the company. The total value of these shares is over $6.6 million. The company now accounts for 0.04% of the hedge fund’s 13F portfolio. In Q2 2021, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported revenue of $0.27 million and ended the quarter with cash and cash equivalents of $443.7 million, compared with $411.6 million. This July, Oppenheimer reiterated its ‘Buy’ rating on Inovio Pharmaceuticals, Inc. (NASDAQ:INO), with a $35 price target. 

As of Q2 2021, 8 hedge funds tracked by Insider Monkey have positions in Inovio Pharmaceuticals, Inc. (NASDAQ:INO), compared with 11 in the previous quarter. The total value of these stakes is $37.4 million.